Market open
Zynex/$ZYXI
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Zynex
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
Ticker
$ZYXI
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
1,100
Website
Zynex Metrics
BasicAdvanced
$255M
Market cap
54.23
P/E ratio
$0.15
EPS
0.53
Beta
-
Dividend rate
Price and volume
Market cap
$255M
Beta
0.53
52-week high
$13.70
52-week low
$7.15
Average daily volume
70K
Financial strength
Current ratio
3.944
Quick ratio
2.982
Long term debt to equity
196.847
Total debt to equity
208.764
Dividend payout ratio (TTM)
0.23%
Interest coverage (TTM)
4.15%
Management effectiveness
Return on assets (TTM)
3.99%
Return on equity (TTM)
10.23%
Valuation
Price to earnings (TTM)
54.234
Price to revenue (TTM)
1.339
Price to book
7.13
Price to tangible book (TTM)
32.3
Price to free cash flow (TTM)
16.696
Growth
Revenue change (TTM)
4.21%
Earnings per share change (TTM)
-66.20%
3-year revenue growth (CAGR)
18.79%
3-year earnings per share growth (CAGR)
-17.11%
What the Analysts think about Zynex
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Zynex stock.
Zynex Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Zynex Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Zynex News
AllArticlesVideos
Zynex partners with VA to offer pain management solutions for veterans
Proactive Investors·2 weeks ago
Zynex CEO outlines plans for 2025 after revenue milestone – ICYMI
Proactive Investors·3 weeks ago
Zynex leverages multi-modality NexWave device to transform pain management
Proactive Investors·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Zynex stock?
Zynex (ZYXI) has a market cap of $255M as of January 02, 2025.
What is the P/E ratio for Zynex stock?
The price to earnings (P/E) ratio for Zynex (ZYXI) stock is 54.23 as of January 02, 2025.
Does Zynex stock pay dividends?
No, Zynex (ZYXI) stock does not pay dividends to its shareholders as of January 02, 2025.
When is the next Zynex dividend payment date?
Zynex (ZYXI) stock does not pay dividends to its shareholders.
What is the beta indicator for Zynex?
Zynex (ZYXI) has a beta rating of 0.53. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.